{"count": 14, "results": [{"_id": "32251713", "pmid": 32251713, "title": "A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells.", "journal": "Mol Cell Endocrinol", "authors": ["Vitali E", "Boemi I", "Piccini S", "Tarantola G", "Smiroldo V", "Lavezzi E", "Brambilla T", "Zerbi A", "Carnaghi C", "Mantovani G", "Spada A", "Lania AG"], "date": "2020-06-01T00:00:00Z", "doi": "10.1016/j.mce.2020.110803", "meta_date_publication": "2020 Jun 1", "meta_volume": "509", "meta_issue": "", "meta_pages": "110803", "score": 50271.305, "text_hl": "A novel insight into the anticancer mechanism of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@pancreatic neuroendocrine tumor@@@ cells.", "citations": {"NLM": "Vitali E, Boemi I, Piccini S, Tarantola G, Smiroldo V, Lavezzi E, Brambilla T, Zerbi A, Carnaghi C, Mantovani G, Spada A, Lania AG. A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells. Mol Cell Endocrinol. 2020 Jun 1;509():110803. PMID: 32251713", "BibTeX": "@article{32251713, title={A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells.}, author={Vitali E and Boemi I and Piccini S and Tarantola G and Smiroldo V and Lavezzi E and Brambilla T and Zerbi A and Carnaghi C and Mantovani G and Spada A and Lania AG}, journal={Mol Cell Endocrinol}, volume={509}, pages={110803}}"}}, {"_id": "32821286", "pmid": 32821286, "pmcid": "PMC7406937", "title": "The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence", "journal": "Therap Adv Gastroenterol", "authors": ["Pusceddu S", "Vernieri C", "Prinzi N", "Torchio M", "Coppa J", "Antista M", "Niger M", "Milione M", "Giacomelli L", "Corti F", "Prisciandaro M", "Monteleone M", "Colombo E", "Di Bartolomeo M", "de Braud F"], "date": "2020-07-31T00:00:00Z", "doi": "10.1177/1756284820927271", "meta_date_publication": "2020", "meta_volume": "13", "meta_issue": "", "meta_pages": "1756284820927271", "score": 50263.46, "text_hl": "The potential role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the treatment of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@pancreatic neuroendocrine tumors@@@: a review of preclinical to clinical evidence", "citations": {"NLM": "Pusceddu S, Vernieri C, Prinzi N, Torchio M, Coppa J, Antista M, Niger M, Milione M, Giacomelli L, Corti F, Prisciandaro M, Monteleone M, Colombo E, Di Bartolomeo M, de Braud F. The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence Therap Adv Gastroenterol. 2020;13():1756284820927271. PMID: 32821286", "BibTeX": "@article{32821286, title={The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence}, author={Pusceddu S and Vernieri C and Prinzi N and Torchio M and Coppa J and Antista M and Niger M and Milione M and Giacomelli L and Corti F and Prisciandaro M and Monteleone M and Colombo E and Di Bartolomeo M and de Braud F}, journal={Therap Adv Gastroenterol}, volume={13}, pages={1756284820927271}}"}}, {"_id": "34815475", "pmid": 34815475, "pmcid": "PMC8611048", "title": "EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine", "journal": "Sci Rep", "authors": ["Barazeghi E", "Hellman P", "Norlén O", "Westin G", "Stålberg P"], "date": "2021-11-23T00:00:00Z", "doi": "10.1038/s41598-021-02181-7", "meta_date_publication": "2021 Nov 23", "meta_volume": "11", "meta_issue": "1", "meta_pages": "22733", "score": 50262.375, "text_hl": "Therefore, in addition to the inhibitory effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @GENE_MTOR @GENE_2475 @@@mTOR@@@ signaling pathway in NETs, our results suggested that downregulation of @GENE_EZH2 @GENE_2146 @@@EZH2@@@ can also partially contribute to the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-antitumor effect in @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@SI-NETs@@@. ", "citations": {"NLM": "Barazeghi E, Hellman P, Norlén O, Westin G, Stålberg P. EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine Sci Rep. 2021 Nov 23;11(1):22733. PMID: 34815475", "BibTeX": "@article{34815475, title={EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine}, author={Barazeghi E and Hellman P and Norlén O and Westin G and Stålberg P}, journal={Sci Rep}, volume={11}, number={1}, pages={22733}}"}}, {"_id": "31892560", "pmid": 31892560, "title": "Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.", "journal": "Anticancer Res", "authors": ["Yamana H", "Kato K", "Kobara H", "Fujihara S", "Fujita K", "Namima D", "Fujita N", "Kobayashi K", "Kamada H", "Morishita A", "Tsutsui K", "Iwama H", "Masaki T"], "date": "2020-01-01T00:00:00Z", "doi": "10.21873/anticanres.13933", "meta_date_publication": "2020 Jan", "meta_volume": "40", "meta_issue": "1", "meta_pages": "121-132", "score": 50259.324, "text_hl": "However, little is known about the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@pNETs@@@. ", "citations": {"NLM": "Yamana H, Kato K, Kobara H, Fujihara S, Fujita K, Namima D, Fujita N, Kobayashi K, Kamada H, Morishita A, Tsutsui K, Iwama H, Masaki T. Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis. Anticancer Res. 2020 Jan;40(1):121-132. PMID: 31892560", "BibTeX": "@article{31892560, title={Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.}, author={Yamana H and Kato K and Kobara H and Fujihara S and Fujita K and Namima D and Fujita N and Kobayashi K and Kamada H and Morishita A and Tsutsui K and Iwama H and Masaki T}, journal={Anticancer Res}, volume={40}, number={1}, pages={121-132}}"}}, {"_id": "38098114", "pmid": 38098114, "pmcid": "PMC10722662", "title": "Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2", "journal": "J Hematol Oncol", "authors": ["Pusceddu S", "Corti F", "Prinzi N", "Nichetti F", "Ljevar S", "Busico A", "Cascella T", "Leporati R", "Oldani S", "Pircher CC", "Coppa J", "Resi V", "Milione M", "Maccauro M", "Miceli R", "Tamborini E", "Perrone F", "Spreafico C", "Niger M", "Morano F", "Pietrantonio F", "Seregni E", "Mariani L", "Mazzaferro V", "Di Liberti G", "Fucà G", "de Braud F", "Vernieri C"], "date": "2023-12-14T00:00:00Z", "doi": "10.1186/s13045-023-01510-9", "meta_date_publication": "2023 Dec 14", "meta_volume": "16", "meta_issue": "1", "meta_pages": "119", "score": 50255.594, "text_hl": "Safety and antitumor activity of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ plus lanreotide in @SPECIES_9606 @@@patients@@@ with advanced @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@gastro-intestinal or lung neuroendocrine tumors@@@: the phase Ib trial MetNET2", "citations": {"NLM": "Pusceddu S, Corti F, Prinzi N, Nichetti F, Ljevar S, Busico A, Cascella T, Leporati R, Oldani S, Pircher CC, Coppa J, Resi V, Milione M, Maccauro M, Miceli R, Tamborini E, Perrone F, Spreafico C, Niger M, Morano F, Pietrantonio F, Seregni E, Mariani L, Mazzaferro V, Di Liberti G, Fucà G, de Braud F, Vernieri C. Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2 J Hematol Oncol. 2023 Dec 14;16(1):119. PMID: 38098114", "BibTeX": "@article{38098114, title={Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2}, author={Pusceddu S and Corti F and Prinzi N and Nichetti F and Ljevar S and Busico A and Cascella T and Leporati R and Oldani S and Pircher CC and Coppa J and Resi V and Milione M and Maccauro M and Miceli R and Tamborini E and Perrone F and Spreafico C and Niger M and Morano F and Pietrantonio F and Seregni E and Mariani L and Mazzaferro V and Di Liberti G and Fucà G and de Braud F and Vernieri C}, journal={J Hematol Oncol}, volume={16}, number={1}, pages={119}}"}}, {"_id": "39679307", "pmid": 39679307, "title": "Limitations and suggestions for type 2 diabetes mellitus and pancreatic neuroendocrine tumors based on meta-analysis.", "journal": "World J Gastroenterol", "authors": ["Huang W", "Huang YQ", "Yang GL"], "date": "2024-12-14T00:00:00Z", "doi": "10.3748/wjg.v30.i46.4947", "meta_date_publication": "2024 Dec 14", "meta_volume": "30", "meta_issue": "46", "meta_pages": "4947-4949", "score": 50252.44, "text_hl": "However, due to the limited number of studies and high heterogeneity, the role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the diagnosis and prognosis of @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@pNETs@@@ remained inconclusive. ", "citations": {"NLM": "Huang W, Huang YQ, Yang GL. Limitations and suggestions for type 2 diabetes mellitus and pancreatic neuroendocrine tumors based on meta-analysis. World J Gastroenterol. 2024 Dec 14;30(46):4947-4949. PMID: 39679307", "BibTeX": "@article{39679307, title={Limitations and suggestions for type 2 diabetes mellitus and pancreatic neuroendocrine tumors based on meta-analysis.}, author={Huang W and Huang YQ and Yang GL}, journal={World J Gastroenterol}, volume={30}, number={46}, pages={4947-4949}}"}}, {"_id": "36630937", "pmid": 36630937, "title": "Lifestyle Factors and Development and Natural Course of Gastroenteropancreatic Neuroendocrine Tumors: A Review of the Literature.", "journal": "Neuroendocrinology", "authors": ["Bogaards M", "May AM", "Hassan FA", "Valk GD", "van Leeuwaarde RS"], "date": "2023-01-01T00:00:00Z", "doi": "10.1159/000527741", "meta_date_publication": "2023", "meta_volume": "113", "meta_issue": "4", "meta_pages": "381-394", "score": 50245.547, "text_hl": "@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ was reported as a risk factor for @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@NETs@@@, while a protective effect was observed with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use. ", "citations": {"NLM": "Bogaards M, May AM, Hassan FA, Valk GD, van Leeuwaarde RS. Lifestyle Factors and Development and Natural Course of Gastroenteropancreatic Neuroendocrine Tumors: A Review of the Literature. Neuroendocrinology. 2023;113(4):381-394. PMID: 36630937", "BibTeX": "@article{36630937, title={Lifestyle Factors and Development and Natural Course of Gastroenteropancreatic Neuroendocrine Tumors: A Review of the Literature.}, author={Bogaards M and May AM and Hassan FA and Valk GD and van Leeuwaarde RS}, journal={Neuroendocrinology}, volume={113}, number={4}, pages={381-394}}"}}, {"_id": "25402373", "pmid": 25402373, "title": "Anticancer effects of metformin on neuroendocrine tumor cells in vitro.", "journal": "Hormones (Athens)", "authors": ["Vlotides G", "Tanyeri A", "Spampatti M", "Zitzmann K", "Chourdakis M", "Spttl C", "Maurer J", "Nölting S", "Göke B", "Auernhammer CJ"], "date": "2014-10-01T00:00:00Z", "doi": "10.14310/horm.2002.1517", "meta_date_publication": "2014 Oct-Dec", "meta_volume": "13", "meta_issue": "4", "meta_pages": "498-508", "score": 50076.25, "text_hl": "Anticancer effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@neuroendocrine tumor@@@ cells in vitro.", "citations": {"NLM": "Vlotides G, Tanyeri A, Spampatti M, Zitzmann K, Chourdakis M, Spttl C, Maurer J, Nölting S, Göke B, Auernhammer CJ. Anticancer effects of metformin on neuroendocrine tumor cells in vitro. Hormones (Athens). 2014 Oct-Dec;13(4):498-508. PMID: 25402373", "BibTeX": "@article{25402373, title={Anticancer effects of metformin on neuroendocrine tumor cells in vitro.}, author={Vlotides G and Tanyeri A and Spampatti M and Zitzmann K and Chourdakis M and Spttl C and Maurer J and Nölting S and Göke B and Auernhammer CJ}, journal={Hormones (Athens)}, volume={13}, number={4}, pages={498-508}}"}}, {"_id": "25076330", "pmid": 25076330, "title": "Chemotherapy and metformin in pancreatic adenocarcinoma and neuroendocrine tumors.", "journal": "JOP", "authors": ["Burney S", "Khawaja KI", "Saif MW", "Masud F"], "date": "2014-07-28T00:00:00Z", "doi": "10.6092/1590-8577/2677", "meta_date_publication": "2014 Jul 28", "meta_volume": "15", "meta_issue": "4", "meta_pages": "313-6", "score": 50073.96, "text_hl": "Chemotherapy and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Pancreatic_Neoplasms @DISEASE_MESH:D010190 @@@pancreatic adenocarcinoma@@@ and @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@neuroendocrine tumors@@@.", "citations": {"NLM": "Burney S, Khawaja KI, Saif MW, Masud F. Chemotherapy and metformin in pancreatic adenocarcinoma and neuroendocrine tumors. JOP. 2014 Jul 28;15(4):313-6. PMID: 25076330", "BibTeX": "@article{25076330, title={Chemotherapy and metformin in pancreatic adenocarcinoma and neuroendocrine tumors.}, author={Burney S and Khawaja KI and Saif MW and Masud F}, journal={JOP}, volume={15}, number={4}, pages={313-6}}"}}, {"_id": "27073573", "pmid": 27073573, "title": "Metformin use and young age lung cancer: A case series report.", "journal": "Oncol Lett", "authors": ["Deng BO", "Wang YI", "Xie D", "Stoddard SM", "Yang P"], "date": "2016-04-01T00:00:00Z", "doi": "10.3892/ol.2016.4307", "meta_date_publication": "2016 Apr", "meta_volume": "11", "meta_issue": "4", "meta_pages": "2899-2902", "score": 50064.45, "text_hl": "It was suggested that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment was not effective in the prevention of @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@pulmonary NETs@@@, and that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may instead induce the occurrence of @<m>DISEASE_Neuroendocrine_Tumors</m> @DISEASE_MESH:D018358 @@@NETs@@@ via as yet unknown signaling pathways. ", "citations": {"NLM": "Deng BO, Wang YI, Xie D, Stoddard SM, Yang P. Metformin use and young age lung cancer: A case series report. Oncol Lett. 2016 Apr;11(4):2899-2902. PMID: 27073573", "BibTeX": "@article{27073573, title={Metformin use and young age lung cancer: A case series report.}, author={Deng BO and Wang YI and Xie D and Stoddard SM and Yang P}, journal={Oncol Lett}, volume={11}, number={4}, pages={2899-2902}}"}}]}